Astrazeneca Pharma
- All
- News
- Videos
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
-
AstraZeneca Rejects "Incorrect" Reports On Covid Jab Efficacy In Elderly
Pharma giant AstraZeneca has defended the efficacy of its Covid-19 vaccine after media reports said the German government had doubts about its effectiveness among those over 65.
-
"Happy New Year, All Risks Paid Off": Adar Poonawalla On Vaccine Approval
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country's drug regulator cleared its Covishield vaccine for emergency approval in India.Mr Poonawalla reiteratedthat the Covishieldvaccine -- developed by Serum Institute of India in pa...
-
After Pfizer, Serum Institute Of India Seeks Approval For Covid Vaccine
Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said.
-
India May Not Get Pfizer Covid Vaccine, Cleared By UK, Anytime Soon: Sources
The coronavirus vaccine developed by American pharma giant Pfizer, which was cleared by the United Kingdom Wednesday and will be rolled out to the public early next week, is unlikely to be available in India at this time, sources have told NDTV
-
Applying For Emergency Use Of Covid Vaccine In 2 Weeks: Serum Institute
The Serum Institute will apply within two weeks for an emergency use license of the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.
-
Prime Minister Narendra Modi To Visit Serum Institute Of India In Pune On November 28
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said on Thursday.
-
PM Modi To Visit Serum Institute That's Making Oxford Vaccine, On Saturday
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said today.
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
-
AstraZeneca Rejects "Incorrect" Reports On Covid Jab Efficacy In Elderly
Pharma giant AstraZeneca has defended the efficacy of its Covid-19 vaccine after media reports said the German government had doubts about its effectiveness among those over 65.
-
"Happy New Year, All Risks Paid Off": Adar Poonawalla On Vaccine Approval
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country's drug regulator cleared its Covishield vaccine for emergency approval in India.Mr Poonawalla reiteratedthat the Covishieldvaccine -- developed by Serum Institute of India in pa...
-
After Pfizer, Serum Institute Of India Seeks Approval For Covid Vaccine
Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said.
-
India May Not Get Pfizer Covid Vaccine, Cleared By UK, Anytime Soon: Sources
The coronavirus vaccine developed by American pharma giant Pfizer, which was cleared by the United Kingdom Wednesday and will be rolled out to the public early next week, is unlikely to be available in India at this time, sources have told NDTV
-
Applying For Emergency Use Of Covid Vaccine In 2 Weeks: Serum Institute
The Serum Institute will apply within two weeks for an emergency use license of the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.
-
Prime Minister Narendra Modi To Visit Serum Institute Of India In Pune On November 28
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said on Thursday.
-
PM Modi To Visit Serum Institute That's Making Oxford Vaccine, On Saturday
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said today.
